Aton Pharma, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 5
Rang # Quantité totale PI 309 480
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 656 821
Parent Valeant Pharmaceuticals International, Inc.

Brevets

Marques

1 0
1 0
3 0
0
 
Dernier brevet 2014 - Stereoselective synthesis of met...
Premier brevet 2003 - Methods of inducing terminal dif...

Derniers inventions, produits et services

2014 Invention Stereoselective synthesis of metyrosine. Provided herein are compositions including diastereomers...
2010 Invention Ocular drug delivery devices. A method of forming an ocular delivery device includes exposing a s...
2008 Invention Uses of trientine and penicillamine as countermeasures to metal contamination. Methods are provid...
2005 Invention Histone deacetylase inhibitors. This invention relates to hydroxamic acid derivatives having a ca...
Invention Histone deacetylase inhibitor prodrugs. The present invention is directed to prodrugs of hydroxam...
2004 Invention Diamine and iminodiacetic acid hydroxamic acid derivatives. The present invention relates to a no...
Invention Methods of treating cancer with hdac inhibitors. The present invention relates to methods of trea...
Invention Thiophene and benzothiophene hydroxamic acid derivatives. The present invention relates to a nove...
Invention Method of treating cancer with hdac inhibitors. The present invention relates to methods of treat...
Invention Combination methods of treating cancer. The present invention relates to a method of treating can...
2003 Invention Methods of inducing terminal differentiation. The present invention provides methods of selective...